Imatinib

ADVERTISEMENT

Identification

Molecular formula
C29H31N7O
CAS Number
152459-95-5
IUPAC Name
4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]phenyl]benzamide
Molecular Weight
493.60g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.2500g/cm3
Synonyms
Imatinib
Interesting facts

Interesting Facts about 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]phenyl]benzamide

This compound displays intriguing characteristics that make it a noteworthy subject of study in the field of medicinal chemistry. Known for its potential as a therapeutic agent, it incorporates several unique structural components that contribute to its biological activity. Here are some fascinating aspects:

  • Complex Structure: The compound contains a 4-methylpiperazine moiety, a feature that is often associated with enhanced solubility and bioavailability in drug design.
  • Diverse Biological Targets: Its structure suggests activity against various enzymatic targets, particularly related to cancer therapies, due to its multi-ring framework and the presence of the pyrimidine derivative.
  • Research Potential: Studies focusing on similar compounds have indicated promising results in inhibiting specific pathways involved in tumor growth, making this compound a candidate for future development and testing.
  • Drug Development Insights: Understanding the interaction of this compound with biological receptors is essential for the advancement of pharmacological therapies. It exemplifies how synthetic modifications can influence biological behavior significantly.

As a testament to its complexity and potential, compounds like this are crucial in the continual search for new medications. They highlight the importance of molecular architecture in designing effective anti-cancer agents, revealing how small changes in chemical structure can lead to significant variations in pharmacological effects. The journey from synthesis to application is filled with exciting challenges and discoveries!

ADVERTISEMENT